↓ Skip to main content

EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study

Overview of attention for article published in Frontiers in immunology, April 2022
Altmetric Badge

Mentioned by

twitter
3 X users

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study
Published in
Frontiers in immunology, April 2022
DOI 10.3389/fimmu.2022.877477
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 13%
Student > Bachelor 5 10%
Student > Master 5 10%
Student > Ph. D. Student 3 6%
Other 2 4%
Other 3 6%
Unknown 24 50%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 15 31%
Biochemistry, Genetics and Molecular Biology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Nursing and Health Professions 1 2%
Sports and Recreations 1 2%
Other 1 2%
Unknown 25 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2022.
All research outputs
#24,788,767
of 34,412,533 outputs
Outputs from Frontiers in immunology
#25,938
of 44,806 outputs
Outputs of similar age
#299,603
of 473,471 outputs
Outputs of similar age from Frontiers in immunology
#1,151
of 1,678 outputs
Altmetric has tracked 34,412,533 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 44,806 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,471 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,678 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.